Omni-Biotic stress release psychobiotic shows improvements in brain function, mood, cognition


While stress has become ubiquitous in the last year, with the novel coronavirus (COVID-19) pandemic, political and social unrest, and ongoing uncertainty affecting patients and practitioners alike, Omni-Biotic Stress Release, a clinically studied psychobiotic, offers targeted strains for unparalleled stress management support.

Psychobiotics are a group of probiotics that affect the central nervous system functions and behaviors mediated by the gut-brain axis. While early studies have shown psychobiotics may influence markers of inflammation, decrease cortisol levels, and improve symptoms of depression, anxiety, and other mental health conditions, formula-specific research is limited. Omni-Biotic Stress Release is one of the only evidence-based products on the market, with multiple peer-reviewed clinical studies using its final commercial formulation, including research published in the European Journal of Nutrition, the journal Gut Microbes, and the journal Neurobiology of Stress.

A complex, bidirectional communication network exists between the gut and the central nervous system. One mechanism is the disruption of gut barrier function, which can result in toxin leakage and a hyperinflammatory response. Research shows that the neurogenesis and microglial activation associated with neuroplasticity is regulated by the microbiota.

Although individual differences in stress response have been associated with genetic and environmental factors, it is becoming more widely accepted that bacteria play a vital role in brain development and stress resilience. Omni-Biotic Stress Release has shown positive changes in brain functional connectivity, stress response, memory, and cognition, as well as a decrease in vulnerability to depressed mood. Additionally, research has demonstrated a reduction in bowel irritability commonly associated with stress.

Considering the bidirectional nature of the gut-brain axis, Omni-Biotic Stress Release was designed with both gut-brain axis and gut microbiome support in mind, featuring specific strains identified and extensively analyzed for strong and effective stress management properties.

The stress release product has been tested for gastric survival, intestinal viability, metabolic activity, and extended real-time shelf stability. It is free of common allergens, non-GMO, and vegan, and requires no refrigeration. Conveniently packaged in individual sachets for protection, portability, and personal convenience, Omni-Biotic probiotic powders easily reconstitute in water, dairy, and other beverages.

Stringent development and manufacturing processes, along with a commitment to peer-reviewed evidence, makes Omni-Biotic one of the most trusted and reliable probiotic brands worldwide.

“Based on my own family’s experience with these highly effective formulations, we partnered with Institut Allergosan to bring Omni-Biotic to practitioners [in the United States],” said Hannah Kleinfeld, chief operating officer at AllergoSan USA. “Our commitment to the thoughtful development of focused probiotic formulations is at the foundation of their efficacy, as demonstrated by clinical trial results.”

To learn more about how Omni-Biotic Stress Response can help practitioners better serve their patients, click here